In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

Researchers developed a c-kit antibody-targeted lipid nanoparticle that, following a single intravenous injection, can deliver RNA to HSCs in vivo in rodents.